International union of basic and clinical pharmacology. CXII: adenosine receptors: a further update
AP IJzerman, KA Jacobson, CE Müller… - Pharmacological …, 2022 - ASPET
Our previous International Union of Basic and Clinical Pharmacology report on the
nomenclature and classification of adenosine receptors (2011) contained a number of …
nomenclature and classification of adenosine receptors (2011) contained a number of …
Understanding the neural mechanisms of general anesthesia from interaction with sleep–wake state: a decade of discovery
WW Bao, S Jiang, WM Qu, WX Li, CH Miao… - Pharmacological …, 2023 - ASPET
The development of cutting-edge techniques to study specific brain regions and neural
circuits that regulate sleep–wake brain states and general anesthesia (GA), has increased …
circuits that regulate sleep–wake brain states and general anesthesia (GA), has increased …
Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways
Insomnia is the second most prevalent mental disorder, with no sufficient treatment
available. Despite substantial heritability, insight into the associated genes and …
available. Despite substantial heritability, insight into the associated genes and …
Nucleus accumbens controls wakefulness by a subpopulation of neurons expressing dopamine D1 receptors
Nucleus accumbens (NAc) is involved in behaviors that depend on heightened wakefulness,
but its impact on arousal remains unclear. Here, we demonstrate that NAc dopamine D1 …
but its impact on arousal remains unclear. Here, we demonstrate that NAc dopamine D1 …
Genome-wide association analysis of self-reported daytime sleepiness identifies 42 loci that suggest biological subtypes
Excessive daytime sleepiness (EDS) affects 10–20% of the population and is associated
with substantial functional deficits. Here, we identify 42 loci for self-reported daytime …
with substantial functional deficits. Here, we identify 42 loci for self-reported daytime …
[图书][B] Sleep disorders medicine E-Book: Basic science, technical considerations, and clinical aspects
S Chokroverty - 2009 - books.google.com
Dr. Sudhansu Chokroverty—a world-recognized expert in sleep medicine—presents the
third edition of Sleep Disorders Medicine for the latest developments in this rapidly …
third edition of Sleep Disorders Medicine for the latest developments in this rapidly …
The control of sleep and wakefulness by mesolimbic dopamine systems
The mesolimbic dopamine pathway between the ventral tegmental area (VTA) and the
nucleus accumbens (NAc) plays a central role in motivational behaviors. Recent findings …
nucleus accumbens (NAc) plays a central role in motivational behaviors. Recent findings …
Ventral pallidal GABAergic neurons control wakefulness associated with motivation through the ventral tegmental pathway
The ventral pallidum (VP) regulates motivation, drug addiction, and several behaviors that
rely on heightened arousal. However, the role and underlying neural circuits of the VP in the …
rely on heightened arousal. However, the role and underlying neural circuits of the VP in the …
Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
Y Irukayama-Tomobe, Y Ogawa… - Proceedings of the …, 2017 - National Acad Sciences
Narcolepsy-cataplexy is a debilitating disorder of sleep/wakefulness caused by a loss of
orexin-producing neurons in the lateroposterior hypothalamus. Genetic or pharmacologic …
orexin-producing neurons in the lateroposterior hypothalamus. Genetic or pharmacologic …
40 Hz light flickering promotes sleep through cortical adenosine signaling
Flickering light stimulation has emerged as a promising non-invasive neuromodulation
strategy to alleviate neuropsychiatric disorders. However, the lack of a neurochemical …
strategy to alleviate neuropsychiatric disorders. However, the lack of a neurochemical …